Thomas Stephen Morley, Dr., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adiponectin | 6 | 2019 | 1099 | 0.680 |
Why?
|
Adipocytes | 7 | 2022 | 1182 | 0.610 |
Why?
|
Insulin Resistance | 6 | 2019 | 3861 | 0.350 |
Why?
|
Adipose Tissue | 4 | 2019 | 3278 | 0.250 |
Why?
|
Insulin | 3 | 2017 | 6575 | 0.240 |
Why?
|
Mammary Neoplasms, Animal | 2 | 2022 | 138 | 0.220 |
Why?
|
Adipose Tissue, White | 5 | 2019 | 345 | 0.220 |
Why?
|
Mice, Obese | 2 | 2019 | 424 | 0.180 |
Why?
|
Insulin-Secreting Cells | 2 | 2019 | 891 | 0.180 |
Why?
|
Vascular Endothelial Growth Factor D | 1 | 2019 | 63 | 0.170 |
Why?
|
Lymphangiogenesis | 1 | 2019 | 172 | 0.150 |
Why?
|
Ferritins | 1 | 2019 | 590 | 0.150 |
Why?
|
Adipocytes, White | 1 | 2017 | 89 | 0.140 |
Why?
|
Glucose Intolerance | 1 | 2019 | 577 | 0.130 |
Why?
|
Mice, Transgenic | 6 | 2019 | 9735 | 0.130 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2015 | 188 | 0.130 |
Why?
|
Lymphatic Vessels | 1 | 2019 | 351 | 0.120 |
Why?
|
Adipokines | 2 | 2014 | 318 | 0.120 |
Why?
|
Collagen Type VI | 1 | 2013 | 26 | 0.110 |
Why?
|
Mitochondrial Proteins | 1 | 2019 | 995 | 0.110 |
Why?
|
Gene Knockout Techniques | 1 | 2015 | 808 | 0.110 |
Why?
|
Ceramides | 1 | 2013 | 198 | 0.100 |
Why?
|
Lipid Metabolism | 3 | 2017 | 1887 | 0.100 |
Why?
|
Cold Temperature | 1 | 2015 | 774 | 0.100 |
Why?
|
Obesity | 3 | 2019 | 12705 | 0.100 |
Why?
|
Random Allocation | 1 | 2015 | 2425 | 0.090 |
Why?
|
Mitochondria | 2 | 2019 | 3520 | 0.090 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 1144 | 0.090 |
Why?
|
Intra-Abdominal Fat | 1 | 2014 | 591 | 0.080 |
Why?
|
Energy Metabolism | 2 | 2019 | 2896 | 0.080 |
Why?
|
Homeostasis | 2 | 2017 | 3335 | 0.070 |
Why?
|
Stem Cells | 2 | 2017 | 3563 | 0.070 |
Why?
|
Cisplatin | 1 | 2013 | 1637 | 0.070 |
Why?
|
Regeneration | 1 | 2014 | 1485 | 0.070 |
Why?
|
Hyperplasia | 2 | 2019 | 1183 | 0.060 |
Why?
|
Animals | 12 | 2022 | 168561 | 0.060 |
Why?
|
Inflammation | 4 | 2017 | 10578 | 0.060 |
Why?
|
Feeding Behavior | 1 | 2015 | 3187 | 0.060 |
Why?
|
Glucose Tolerance Test | 2 | 2017 | 1150 | 0.050 |
Why?
|
Mice | 7 | 2019 | 81045 | 0.050 |
Why?
|
Adipogenesis | 2 | 2015 | 358 | 0.050 |
Why?
|
Adipose Tissue, Brown | 2 | 2017 | 754 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2013 | 5095 | 0.050 |
Why?
|
Cell Differentiation | 1 | 2017 | 11470 | 0.040 |
Why?
|
Glucose Clamp Technique | 1 | 2019 | 266 | 0.040 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2019 | 176 | 0.040 |
Why?
|
Lipolysis | 1 | 2019 | 211 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2022 | 20774 | 0.040 |
Why?
|
Aging | 1 | 2015 | 8626 | 0.040 |
Why?
|
Lipase | 1 | 2017 | 315 | 0.030 |
Why?
|
Caveolae | 1 | 2014 | 57 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2022 | 1740 | 0.030 |
Why?
|
Streptozocin | 1 | 2014 | 193 | 0.030 |
Why?
|
Adrenergic Agonists | 1 | 2014 | 58 | 0.030 |
Why?
|
Serum Amyloid A Protein | 1 | 2014 | 121 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2019 | 879 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2017 | 21821 | 0.030 |
Why?
|
Thermogenesis | 1 | 2017 | 429 | 0.030 |
Why?
|
Caveolin 1 | 1 | 2014 | 264 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2017 | 786 | 0.030 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2014 | 301 | 0.030 |
Why?
|
Sphingolipids | 1 | 2013 | 159 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2019 | 2077 | 0.030 |
Why?
|
Cell Count | 1 | 2015 | 1831 | 0.030 |
Why?
|
Sphingosine | 1 | 2013 | 307 | 0.020 |
Why?
|
Lysophospholipids | 1 | 2013 | 331 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2017 | 14554 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3564 | 0.020 |
Why?
|
Thiazolidinediones | 1 | 2013 | 476 | 0.020 |
Why?
|
Gene Deletion | 1 | 2017 | 2751 | 0.020 |
Why?
|
Male | 6 | 2019 | 349538 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2017 | 9639 | 0.020 |
Why?
|
Organ Specificity | 1 | 2013 | 2003 | 0.020 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2014 | 1121 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2013 | 713 | 0.020 |
Why?
|
Fatty Liver | 1 | 2014 | 728 | 0.020 |
Why?
|
Models, Animal | 1 | 2014 | 2170 | 0.020 |
Why?
|
Cell Lineage | 1 | 2015 | 2504 | 0.020 |
Why?
|
Metabolic Diseases | 1 | 2013 | 657 | 0.020 |
Why?
|
Transcription Factors | 2 | 2017 | 12164 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2014 | 2211 | 0.020 |
Why?
|
Mice, Nude | 1 | 2013 | 3689 | 0.020 |
Why?
|
Fibrosis | 1 | 2013 | 2026 | 0.020 |
Why?
|
Leptin | 1 | 2014 | 1593 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 5867 | 0.020 |
Why?
|
Cell Membrane | 1 | 2015 | 3744 | 0.020 |
Why?
|
Neoplasms | 1 | 2014 | 21596 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2013 | 6313 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2013 | 4771 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6608 | 0.020 |
Why?
|
Female | 6 | 2022 | 379592 | 0.010 |
Why?
|
Lipids | 1 | 2014 | 3302 | 0.010 |
Why?
|
Body Weight | 1 | 2014 | 4664 | 0.010 |
Why?
|
Blood Glucose | 1 | 2017 | 6249 | 0.010 |
Why?
|
Weight Loss | 1 | 2014 | 2604 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2013 | 2633 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2014 | 4414 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2014 | 2542 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10248 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9410 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16331 | 0.010 |
Why?
|
Macrophages | 1 | 2013 | 5655 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2013 | 5163 | 0.010 |
Why?
|
Disease Progression | 1 | 2014 | 13256 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2014 | 4823 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2013 | 9274 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 40054 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18006 | 0.010 |
Why?
|
Humans | 3 | 2022 | 742088 | 0.010 |
Why?
|